These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 172607)

  • 1. Increase in cyclic AMP levels and vasopressin release in response to angiotensin I in neurohypophyses: blockade following inhibition of the converting enzyme.
    Sirois P; Gagnon DJ
    J Neurochem; 1975 Nov; 25(5):727-9. PubMed ID: 172607
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurohypophyseal effects of angiotensin: further studies.
    Gagnon DJ; Sirois P
    J Pharm Pharmacol; 1976 Oct; 28(10):777-8. PubMed ID: 10376
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulation by angiotensin II of the release of vasopressin from incubated rat neurohypophyses---possible involvement of cyclic AMP.
    Gagnon DJ; Sirois P; Boucher PJ
    Clin Exp Pharmacol Physiol; 1975; 2(4):305-13. PubMed ID: 168023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of converting enzyme inhibition on the release of vasopressin induced by angiotensin.
    Knepel W; Meyer DK
    Br J Pharmacol; 1980; 71(1):337-41. PubMed ID: 6162497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic nucleotides and the release of vasopressin from the rat posterior pituitary gland.
    Vale MR; Hope DB
    J Neurochem; 1982 Aug; 39(2):569-73. PubMed ID: 6283027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of specific inhibitors of angiotensin I converting enzyme (kininase II).
    Cushman DW; Cheung HS; Sabo EF; Rubin B; Ondetti MA
    Fed Proc; 1979 Dec; 38(13):2778-82. PubMed ID: 228989
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats.
    Harris PJ; Munro JO
    J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High angiotensin-converting enzyme activity in the neurohypophysis of Brattleboro rats.
    Chevillard C; Saavedra JM
    Science; 1982 May; 216(4546):646-7. PubMed ID: 6280284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for angiotensin analogues to accumulate cyclic AMP and release vasopressin from the incubated rat neurohypophysis.
    Gagnon DJ; Sirois P; Park WK
    Clin Exp Pharmacol Physiol; 1975; 2(4):315-22. PubMed ID: 168024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the inhibition of angiotensin converting enzyme on renin release mediated by exercise in man [proceedings].
    Khokhar AM; Havard CW; Slater JD
    J Endocrinol; 1979 Oct; 83(1):37P-38P. PubMed ID: 230274
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential distribution of angiotensin converting enzyme in the anterior and posterior lobe of the rat pituitary.
    Yang HY; Neff NH
    J Neurochem; 1973 Oct; 21(4):1035-6. PubMed ID: 4356836
    [No Abstract]   [Full Text] [Related]  

  • 12. Atrial natriuretic factor inhibits vasopressin secretion from rat posterior pituitary.
    Obana K; Naruse M; Inagami T; Brown AB; Naruse K; Kurimoto F; Sakurai H; Demura H; Shizume K
    Biochem Biophys Res Commun; 1985 Nov; 132(3):1088-94. PubMed ID: 2934060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to angiotensins I and II and to AI-converting-enzyme inhibitor in a shark.
    Opdyke DF; Holcombe R
    Am J Physiol; 1976 Dec; 231(6):1750-3. PubMed ID: 12664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine mechanisms in the pathogenesis of essential hypertension. VI. Blockade of the renin-angiotensin system as a therapeutical basis.
    Păuşescu E
    Physiologie; 1982; 19(4):245-64. PubMed ID: 6185963
    [No Abstract]   [Full Text] [Related]  

  • 15. Forskolin inhibits potassium-evoked release of vasopressin from rat neurohypophyses.
    Bowman D; Lategan TW; Hope DB
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):358-60. PubMed ID: 2984589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin release to central and peripheral angiotensin II in rats with lesions of the subfornical organ.
    Iovino M; Steardo L
    Brain Res; 1984 Nov; 322(2):365-8. PubMed ID: 6509326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of converting enzyme blockade on isoprenaline- and angiotensin I-induced drinking.
    Hertting G; Meyer DK
    Br J Pharmacol; 1974 Nov; 52(3):381-6. PubMed ID: 4376436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cyclic nucleotides on vasopressin release from the isolated neural lobe of normal and dehydrated rats and the intact hypothalamo-neurohypophysial system.
    Mathison R; Lederis K
    Proc West Pharmacol Soc; 1976; 19():457-60. PubMed ID: 186812
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of angiotensin converting enzyme inhibitors. A review.
    Nelson EB; Pool JL; Taylor AA
    Am J Med; 1986 Oct; 81(4C):13-8. PubMed ID: 3022580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril and teprotide as discriminators of angiotensin-converting enzyme activity in brain tissue.
    Zubenko GS; Nixon RA
    Neurosci Lett; 1985 Sep; 60(1):33-7. PubMed ID: 2997673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.